Adding an anterior capsular block to a steroid injection for frozen shoulder pain
Comparative Study Between Shoulder Anterior Capsular Block Plus Steroid Injection Versus Steroid Injection Alone for Pain Management in Adhesive Capsulitis: A Randomized Trial
This test will see if adding an anterior capsular block to an intraarticular steroid injection gives better and longer pain relief for people aged 41–65 with adhesive capsulitis.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 41 Years to 65 Years |
| Sex | All |
| Sponsor | Zagazig University Government |
| Locations | 1 site (Zagazig) |
| Trial ID | NCT07235982 on ClinicalTrials.gov |
What this trial studies
Participants with adhesive capsulitis will receive either a combined shoulder anterior capsular block plus intraarticular steroid injection or an intraarticular steroid injection alone and will be followed for eight weeks. Pain will be tracked with a Visual Analogue Scale at baseline and during follow-up, and total rescue ibuprofen use will be recorded. Secondary measures include the Shoulder Pain and Disability Index, recording of block- or injection-related complications, and a five-point patient satisfaction rating. The procedures are performed at a single center (Zagazig University Faculty of Medicine) by clinical staff experienced in injections and regional blocks.
Who should consider this trial
Good fit: Ideal candidates are adults aged 41–65 with adhesive capsulitis who are ASA I–II, have had at least two weeks of failed conservative treatment, and have no secondary shoulder pathology or contraindications to regional block or steroids.
Not a fit: Patients with secondary shoulder disorders, contraindications to regional blocks or steroid/bupivacaine allergy, advanced uncontrolled systemic disease, or prior surgery/neuropathy in the involved limb are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, patients could gain faster or greater pain relief and reduce their need for additional pain medication.
How similar studies have performed: Intraarticular steroids and regional shoulder blocks have both shown short-term pain relief in prior work, but direct evidence on combining an anterior capsular block with steroid injection for adhesive capsulitis is limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients acceptance * Age: 41-65 years old * Sex: both sex (males or females). * Physical status: American Society of Anesthesiologist (ASA) І, II. * Patients attend orthopedic or pain clinic with complaint of shoulder pain and stiffness. These patients received conservative management of pain with no relief of symptoms for at least 2 weeks. Exclusion Criteria: * Shoulder pain due to secondary causes, e.g. acute trauma, fractures, bony deformity, glenohumeral joint pathology, acromioclavicular joint pathology and rotator cuff disorder. * Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site) * Patients with known history of allergy to the study drugs (bupivacaine and methylprednisolone). * Advanced hepatic, renal, cardiovascular, neurologic and respiratory diseases, uncontrolled diabetes mellitus and thyroid. * History of neuropathy in the involved limb or previous revision surgery.
Where this trial is running
Zagazig
- Faculity of Medicine, Zagazig University — Zagazig, Egypt (Recruiting)
Study contacts
- Principal investigator: Dina Salem, MD — Faculty of Medicine, Zagazig University
- Study coordinator: Dina Salem, MD
- Email: dinamaghraby@yahoo.com
- Phone: 01099333513
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.